Vertex Pharmaceuticals Incorporated announced the opening of its new expanded research facility in Torrey Pines, San Diego, USA.
The new site represents a significant expansion of the Company’s research presence in the area, and its continued investment in the local economy. The San Diego site is one of Vertex’s three global research hubs, and is where the Company’s three breakthrough cystic fibrosis (CF) medicines were discovered.
More than 70 percent of the new facility is dedicated to state-of-the-art lab and research space. It features a learning lab for science, technology, engineering, arts and math (STEAM) education programs, expanding on the Company’s commitment to inspire and equip the next generation of leaders in science; and an incubator suite for external collaboration.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious and life-threatening diseases. In addition to clinical development programs in CF, Vertex has more than a dozen ongoing research programs focused on the underlying mechanisms of other serious diseases.
Founded in 1989 in Cambridge, USA, Vertex’s headquarters is now located in Boston’s Innovation District. Today, the company has research and development sites and commercial offices in the United States, Europe, Canada and Australia.